Advertisement

Chemoprevention of Colon Cancer

  • Mary Mulcahy
  • Al BensonIII
Chapter
  • 99 Downloads
Part of the Cancer Treatment and Research book series (CTAR, volume 106)

Abstract

Adenocarcinoma of the large bowel presents a major public health problem. It affects about 1 person in 20 in the United States and Western countries [1]. It is the second most common cause of cancer death in American males, and the third most common cause in American females. When diagnosed and treated in its early stages, it is a highly curable disease. However, only half of all patients who present with colorectal cancer are cured by primary resection [2]. Primary prevention through the identification and eradication of risk factors responsible for the development of colorectal cancer is an area of active research throughout the world. Both environmental and genetic factors have been causally related to the development of colorectal cancer. Secondary prevention, by identifying premalignant lesions through screening techniques such as endoscopy, fecal occult blood testing, air-contrast barium enema, and CT colonography may potentially lead to a dramatic reduction in mortality. As a result of our improved understanding of the pathogenesis of colorectal cancer, the role of chemoprevention, either as primary or secondary prevention, and the targets for prevention, have been more readily defined.

Keywords

Colorectal Cancer Colon Cancer Bile Acid Familial Adenomatous Polyposis Adenomatous Polyposis Coli 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Cancer Society (ACS). Cancer Facts and Figures-1997. Atlanta (GA):ACS;1997.Google Scholar
  2. 2.
    August DA, Ottow RH, Sugarbaker PH. Clinical Perspective of Human Colorectal Cancer Metastasis. Cancer Metastasis Reviews.3:303–24, 1984.PubMedGoogle Scholar
  3. 3.
    Parkin DM, Muir CS, et al. Cancer Incidence in Five Continents. Lyon (France): International Agency for research on Cancer; 1992.Google Scholar
  4. 4.
    McMichael AJ, Giles GG. Cancer in Migrants to Australia: Extending the Descriptive Epidemiological Data. Cancer Research 48:751–756, 1988.PubMedGoogle Scholar
  5. 5.
    Haenszel W. Cancer Mortality Among the Foreign Born in the United States. Journal of the National Cancer Institute 26:37–132, 1961.PubMedGoogle Scholar
  6. 6.
    Haenszel W, Berg JW, et al. Large Bowel Cancer in Hawaiian Japanese. Journal of the National Cancer Institute 51:1765–1779, 1973.PubMedGoogle Scholar
  7. 7.
    Phillips R. Role of Life-Style and Dietary Habits in Risk of Cancer Among Seventh-Day Adventists. Cancer Research 35:3513–3522, 1975.PubMedGoogle Scholar
  8. 8.
    Sign PN, Fraser GE. Dietary Risk Factors for Colon Cancer in a Low-Risk Population. American Journal of Epidemiology 148:761–774, 1998.Google Scholar
  9. 9.
    Garland C, Garland FC. Do Sunlight and Vitamin D Reduce the Likelihood of Colon Cancer? International Journal of Epidemiology 27:155, 1979.Google Scholar
  10. 10.
    Bodmer WF, Bailey CJ, et al. Localization of the Gene for Familial Adenomatous Polyposis in Chromosome 5. Nature 328:614–616, 1987.PubMedGoogle Scholar
  11. 11.
    Leppert M, Dobbs M, et al. The Gene for Familial Polyposis Coli Maps to the Long Arm of Chromosome 5. Science 238:1411–1413, 1987.PubMedGoogle Scholar
  12. 12.
    Gardner EJ, Richards RC. Multiple Cutaneous and Subcutaneous Lesions Occurring Simultaneously with Hereditary Polyposis and Osteomatosis. American Journal of Human Genetics 5:139–147, 1953.PubMedGoogle Scholar
  13. 13.
    Hamilton SR, Lie B, et al. The Molecular Basis of Turcot’s Syndrome. New England Journal of Medicine 332:839–847, 1995.PubMedGoogle Scholar
  14. 14.
    Leppert M, Burt R, et al. Genetic Analysis of an Inherited Predisposition to Colon Cancer in a Family with a Variable Number of Adenomatous Polyps. New England Journal of Medicine 322:904–908, 1990.PubMedGoogle Scholar
  15. 15.
    Lynch PM, Lynch HT. Colon Cancer Genetics. New York (NY): Van Nostrand Rheinhold; 1985.Google Scholar
  16. 16.
    Aaltonen LA, Peltomaki P, et al. Clues to the Pathogenesis of Familial Colorectal Cancer. Science 260:812–816, 1993.PubMedGoogle Scholar
  17. 17.
    Thibodeau SN, Bren G, Schaid D. Microsatellite Instability in Cancer of the Proximal Colon. Science 260:816–819, 1993.PubMedGoogle Scholar
  18. 18.
    Winawer SJ, Sherlock P, et al. Screening for Colorectal Cancer. Gastroenterology 70:783–789, 1976.PubMedGoogle Scholar
  19. 19.
    Fearon ER, Vogelstein B. A Genetic Model for Colorectal Tumorigenesis. Cell 61:759–767, 1990.Google Scholar
  20. 20.
    Potter JD. Colorectal Cancer: Molecules and Populations. Journal of the National Cancer Institute 91:916–932, 1999.PubMedGoogle Scholar
  21. 21.
    Brentnall TA. Risk Factors for Colorectal Cancer in Inflammatory Bowel Disease. In: Advances in Inflammatory Bowel Diseases. Falk Symposium No. 106, Rutgeerts P, Colombel JF, et al Eds. Dordrecht (The Netherlands): Kluwer Academic Publishers; 159167, 1999.Google Scholar
  22. 22.
    Groden J, Thliveris A, et al. Identification and Characterization of the Familial Adenomatous Polyposis Coli Gene. Cell 66:589–600, 1991.PubMedGoogle Scholar
  23. 23.
    Nathke IS, Adams CL, et al. The Adenomatous Polyposis Coli Tumor Suppressor Protein Localizes to Plasma Membrane Sites Involved in Active Cell Migration. Journal of Cell Biology 134:165–179, 1996.PubMedGoogle Scholar
  24. 24.
    Barth AI, Nathke IS, et al. Cadherins, Catenins and APC Protein: Interplay Between Cytoskeletal Complexes and Signaling Pathways. Current Opinions in Cell Biology 9:683–690, 1997.Google Scholar
  25. 25.
    Lynch HT, Lynch PM, et al. The Cancer Family Syndrome: A Status Report. Diseases of the Colon and Rectum 24:311–322, 1981.Google Scholar
  26. 26.
    Feinberg AP, Gehrke CW, et al. Reduced Genomic 5-methylcytosine Content in Human Colonic Neoplasia. Cancer Research 48:1159–1161, 1988.PubMedGoogle Scholar
  27. 27.
    Goelz SE, Vogelstein B, et al. Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms. Science 228:187–190, 1985.PubMedGoogle Scholar
  28. 28.
    Silverman AL, Park J-G, et al. Abnormal Methylation of the Calcitonin Gene in Human Colonic Neoplasms. Cancer Research 49:3468–3473, 1989.PubMedGoogle Scholar
  29. 29.
    Issa JJ, Ottaviano YL, et al. Methylation of the Oestrogen Receptor CpG Island Links Ageing and Neoplasia in Human Colon. Nature Genetics 7:536–540, 1994.PubMedGoogle Scholar
  30. 30.
    Cravo M, Fidalgo P, et al. DNA Methylation as an Intermediate Biomarker in Colorectal Cancer: Modulation by Folic Acid Supplementation. European Journal of Cancer Prevention. 3:473–9, 1994.PubMedGoogle Scholar
  31. 31.
    Schatzkin A, Freedman LS, et al. Validation of Intermediate End Points in Cancer Research. Journal of the National Cancer Institute 82:1746–1752, 1990.PubMedGoogle Scholar
  32. 32.
    O’Brien MJ, Winawer SJ, et al. The National Polyp Study: Patient and Polyp Characteristics Associated with High-Grade Dysplasia in Adenomas. Gastroenterology 98:371–379, 1990.PubMedGoogle Scholar
  33. 33.
    Winawer SJ, O’Brien MJ, et al. Risk and Surveillance of Individuals with Colorectal Polyps. WHO Collaborative Centre for the Prevention of Colorectal Cancer. Bulletin of the World Health Organization 68:789–795, 1990.PubMedGoogle Scholar
  34. 34.
    Hixson LJ, Fennerty MB, et al. Two-Year Incidence of Colonic Adenomas Developing After Tandem Colonoscopy. American Journal of Gastroenterology 89:687–691, 1994.PubMedGoogle Scholar
  35. 35.
    Hixson LJ, Fennerty MB, et al. Prospective Study of the Frequency and Size Distribution of Polyps Missed by Colonoscopy. Journal of the National Cancer Institute 83:1769–1772, 1990.Google Scholar
  36. 36.
    Fennerty MB, Davidson J, et al. Are Endoscopic Measurements of Colonic Polyps Reliable? American Journal of Gastroenterology 88:496–500, 1993.PubMedGoogle Scholar
  37. 37.
    Risio M, Candelaresi G, Rossini FP. Bromodeoxyuridine Uptake and Proliferating Cell Nuclear Antigen Expression Throughout the Colorectal Tumor Sequence. Cancer Epidemiology, Biomarkers & Prevention. 2:363–7, 1993 Jul-Aug.Google Scholar
  38. 38.
    Bedi A, Pasricha PJ, et al. Inhibition of Apoptosis During Development in Colorectal Cancer. Cancer Research 55:1811–1816, 1995.PubMedGoogle Scholar
  39. 39.
    Sinicrope FA, Ruan SB, et al. Bcl-2 and p53 Oncoprotein Expression During Colorectal Tumorigenesis. Cancer Research 55:237–241, 1995.PubMedGoogle Scholar
  40. 40.
    Einspahr JG, Alberts DS, et al. Surrogate End-Point Biomarkers as Measures of Colon Cancer Risk and Their Use in Cancer Chemoprevention Trials. Cancer Epidemiology, Biomarkers and Prevention 6:37–48, 1997.Google Scholar
  41. 41.
    Smith WL. Prostanoid Biosynthesis and Mechanisms of Action. American Journal of Physiology 263:F181–F191, 1992.PubMedGoogle Scholar
  42. 42.
    Goodlad RA, Madgwick AJ, et al. Prostaglandins and the Gastric Epithelium: Effects of Misoprostol on Gastric Epithelial Cell Proliferation in the Dog. Gut 30:316–321, 1989.PubMedGoogle Scholar
  43. 43.
    Eberhart CE, Coffey RJ, et al. Up-regulation of Cyclooxygenase 2 Gene Expression in Human Colorectal Adenomas and Adenocarcinomas. Gastroenterology 107:1183–1188, 1994.PubMedGoogle Scholar
  44. 44.
    Kargman SL, O’Neil GP, et al. Expression of Prostaglandin G/H Synthase–1 and –2 Protein in Human Colon Cancer. Cancer Research 55:2556–2559, 1995.PubMedGoogle Scholar
  45. 45.
    Dannenberg AJ and Zakim D. Chemoprevention of Colorectal Cancer Through Inhibition of Cyclooxygenase-2. Seminars in Oncology 26:499–504, 1999.PubMedGoogle Scholar
  46. 46.
    Pegg AE. Polyamine Metabolism and its Importance in Neoplastic Growth and a Target for Chemotherapy. Cancer Research 48:759–774, 1988.PubMedGoogle Scholar
  47. 47.
    Luk GD and Baylin SB. Ornithine Decarboxylase as a Biologic Marker in Familial Colonic Polyposis. New England Journal of Medicine 311:80–83, 1984.PubMedGoogle Scholar
  48. 48.
    Meyskens Jr. FL, Gerner EW, et al. Effect of cc-Difluoromethylornithine on Rectal Mucosa] Levels of Polyamines in a Randomized, Double-Blinded Trial for Colon Cancer Prevention. Journal of the National Cancer Institute 90:1212–1218, 1998.PubMedGoogle Scholar
  49. 49.
    Meyskens Jr. FL, Emerson SS, et al. Dose De-Escalation Chemoprevention Trial of ccdifluoromethylornithine in Patients with Colon Polyps. Journal of the National Cancer Institute 86:1122–1130, 1994.PubMedGoogle Scholar
  50. 50.
    Vogelstein B, Fearon ER, et al. Genetic Alterations During Colorectal-Tumor Development. New England Journal of Medicine 319:525–532, 1988.PubMedGoogle Scholar
  51. 51.
    Baker SJ, Fearon ER, et al. Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas. Science 244:217–221, 1989.PubMedGoogle Scholar
  52. 52.
    Fearon ER, Cho KR, et al. Identification of a Chromosome 18q Gene that is Altered in Colorectal Cancer. Science 247:49–56, 1990.PubMedGoogle Scholar
  53. 53.
    Vogelstein B, Fearon ER, et al. Allelotype of Colorectal Carcinomas. Science 244:207–211, 1989.PubMedGoogle Scholar
  54. 54.
    Afshari CA, Nuwaysir EF, Barrett JC. Application of Complementary DNA Technology to Carcinogen Identification, Toxicology, and Drug Safety Evaluation. Cancer Research 59:4759–4760, 1999PubMedGoogle Scholar
  55. 55.
    Mamett LJ. Aspirin and the Potential Role of Prostaglandins in Colon Cancer. Cancer Research 52:5575–5589, 1992.Google Scholar
  56. 56.
    Tsujii M and DuBois R. Alterations in Cellular Adhesion and Apoptosis in Epithelial Cells Overexpressing Cox-2. Cell 83:493–450, 1995.PubMedGoogle Scholar
  57. 57.
    Dubois RN, Shao J, et al. GI Delay in Cells Overexpressing Prostaglandin Endoperoxide Synthase-2. Cancer Research 56:733–737, 1996.PubMedGoogle Scholar
  58. 58.
    Hanif R, Pittas A, et al. Effects of Nonsteroidal Anti-Inflammatory Drugs on Proliferation and in Induction of Apoptosis in Colon Cancer Cells by a Prostaglandin Independent Pathway. Biochemical Pharmacology 52:237–245, 1996.PubMedGoogle Scholar
  59. 59.
    Ruschoff J, Wallinger S, et al. Aspirin Suppresses the Mutator Phenotype Associated with Hereditary Nonpolyposis Colorectal Cancer by Genetic Selection. Proceedings of the National Academy of Sciences 95:11303–11306, 1998Google Scholar
  60. 60.
    Krishnan K, Ruffin MT, Brenner DE. Clinical Models of Chemoprevention for Colon Cancer. Hematology/Oncology Clinics of North America 12:1079–1113, 1998.PubMedGoogle Scholar
  61. 61.
    Laasko M, Mutru 0, et al. Cancer Mortality in Patients with Rheumatoid Arthritis. Journal of Rheumatology 13:522–526, 1986.Google Scholar
  62. 62.
    Itoh H, Ikeda S, et al. Treatment of Desmoid Tumors in Gardner’s Syndrome. Report of a Case. Diseases of the Colon & Rectum. 31:459–61, 1988.Google Scholar
  63. 63.
    Giardello FM, Hamilton SR, et al. Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis. New England Journal of Medicine 328:1313–1316, 1993.Google Scholar
  64. 64.
    Steinbach G, Lynch PM, et al. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis. New England Journal of Medicine 342:1946–1952, 2000.PubMedGoogle Scholar
  65. 65.
    Hixson L, Earnest D, et al. NSAID Effect on Sporadic Colon Polyps. American Journal of Gastroenterology 88:1652–1656, 1993.PubMedGoogle Scholar
  66. 66.
    Matsuhashi N, Nalcajima A, et al. Effects of Sulindac on Sporadic Colorectal Adenomatous Polyps. Gut 40:344–349, 1997PubMedGoogle Scholar
  67. 67.
    Giovannucci E, Rimm EB, et al. Aspirin Use and the Risk of Colorectal Cancer and Adenoma in Male Health Professionals. Annals of Internal Medicine 121:241–246, 1994.PubMedGoogle Scholar
  68. 68.
    Giovannucci E, Egan KM, et al. Aspirin and the Risk of Colorectal Cancer in Women. New England Journal of Medicine 333:609–614, 1995.PubMedGoogle Scholar
  69. 69.
    Starner T, Glynn RJ, et al. Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians Health Study. Annals of Internal Medicine 128:713–720, 1998.Google Scholar
  70. 70.
    Lipkin M and Newmark H. Calcium and the Prevention of Colon Cancer. Journal of Cellular Biochemistry S22: 65–73, 1995.Google Scholar
  71. 71.
    Garland C, Barrett-Conner E, et al. Dietary Vitamin D and Calcium and Risk of Colorectal Cancer: A 19-Year Prospective Study in Men. The Lancet 1:307–309, 1985.Google Scholar
  72. 72.
    Alberts DS, Ritenbaugh C, et al. Randomized, Double-Blinded, Placebo-Controlled Study of Effect of Wheat Bran Fiber and Calcium on Fecal Bile Acids in Patients with Resected Adenomatous Colon Polyps. Journal of the National Cancer Institute 88:81–92, 1996.PubMedGoogle Scholar
  73. 73.
    Lans J, Jaszewski R, et al. Supplemental Calcium Suppresses Colonic Mucosal Ornithine Decarboxylase Activity in Elderly Patients with Adenomatous Polyps. Cancer Research 51:3416–3419, 1991.PubMedGoogle Scholar
  74. 74.
    Slater SJ, Kelly MB, et al. Direct Activation of Protein Kinase C by 1,25-dihydroxy Vitamin D3. Journal of Biological Chemistry 270:6639–6643, 1995.PubMedGoogle Scholar
  75. 75.
    Newmark HL, Wargovich MJ and Bruce WR. Colon Cancer and Dietary Fat, Phosphate, and Calcium: A Hypothesis. Journal of the National Cancer Institute 72:1323–1325, 1984.PubMedGoogle Scholar
  76. 76.
    Holt PR, Atillasoy EO, et al. Modulation of Abnormal Colonic Epithelial Cell Proliferation and Differentiation by Low-Fat Dairy Foods: A Randomized Controlled Trial. JAMA 280:1074–1079, 1998.PubMedGoogle Scholar
  77. 77.
    Bostick RM, Fosdick L, et al. Calcium and Colorectal Epithelial Cell Proliferation in Sporadic Adenoma Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Journal of the National Cancer Institute 87:1307–1315, 1995.PubMedGoogle Scholar
  78. 78.
    Stern HS, Gregoire RC, at al. Long-Term Effects of Dietary Calcium on Risk Markers for Colon Cancer in Patients with Familial Polyposis. Surgery 108:528–533, 1990.PubMedGoogle Scholar
  79. 79.
    Baron JA, Tosteson TD, et al. Calcium Supplementation and Rectal Mucosa] Proliferation: A randomized controlled Trial. Journal of the National Cancer Institute 87:1303–1307, 1995.PubMedGoogle Scholar
  80. 80.
    Baron JA, Beach M, et al. Calcium Supplements for the Prevention of Colorectal Adenomas. New England Journal of Medicine 340:101–108, 1999PubMedGoogle Scholar
  81. 81.
    Meyskens Jr. FL and Gerner EW. Development of Difluoromethylornithine as a Chemoprevention Agent for the Management of Colon Cancer. Journal of Cellular Biochemistry S22: 126–131, 1995.Google Scholar
  82. 82.
    Verma AK. Inhibition of Tumor Promotion by DL-alpha-difluoromethylornithine, a Specific Irreversible Inhibitor of Omithine Decarboxylase. Basic Life Sciences 52:195–204, 1990.Google Scholar
  83. 83.
    Auvinen M. Cell Transformation, Invasion, and Angiogenesis: A Regulatory Role for Ornithine Decarboxylase and Polyamines? Journal of the National Cancer Institute 89:533–537, 1997.PubMedGoogle Scholar
  84. 84.
    Wallon UM, Shassetx LR, et al. Polyamine-Dependent Expression of the Matrix Metalloprotinase Matrilysin in a Human Colon Cancer-Derived Cell Line. Molecular Carcineogenesis 11:138–144, 1994.Google Scholar
  85. 85.
    Love RR, Carbone PP, et al. Randomized Phase I Chemoprevention Dose-Seeking Study of cc-Difluoromethylornithine. Journal of the National Cancer Institute 85:732–737, 1993.PubMedGoogle Scholar
  86. 86.
    Smith DB. Strand JA. Carter PL. Gardner’s syndrome: Current Concepts and Use of a New Genetic Marker. Military Medicine. 153:289–93, 1988.PubMedGoogle Scholar
  87. 87.
    Meyskens FL, Gerner EW, et al. Effect of a-difluoromethylornithine on Rectal Mucosal Levels of Polyamines in a Randomized, Double-Blinded Trial of Colon Cancer Prevention. Journal of the National Cancer Institute 90:1212–1218, 1998.PubMedGoogle Scholar
  88. 88.
    Fraumeni JF Jr., Lloyd W, et al. Cancer Mortality Among Nuns: Role of Marital Status in Etiology of Neoplastic Disease in Women. Journal of the National Institute of Cancer 42:455–468, 1969.Google Scholar
  89. 89.
    Potter JD, Slattery ML, et al. Colon Cancer: A Review of the Epidemiology. Epidemiology Reviews 15:499–545, 1993.Google Scholar
  90. 90.
    Grodstein F, Martinez E, et al. Postmenopausal Hormone Use and Risk for Colorectal Cancer and Adenoma. Annals of Internal Medicine 128:705–712, 1998.PubMedGoogle Scholar
  91. 91.
    McMichael AJ, Potter JD. Reproduction, Endogenous and Exogenous Sex Hormones, and Colon Cancer: A Review and Hypothesis. Journal of the National Cancer Institute 65:1202–1207, 1980.Google Scholar
  92. 92.
    Block G, Patterson B, Suber A. Fruit, Vegetables, and Cancer Prevention: A Review of the Epidemiological Evidence. Nutrition and Cancer 18:1–29, 1992.Google Scholar
  93. 93.
    Steinmetz KA, Potter JD. Vegetables, Fruit, and Cancer. I. Epidemiology. Cancer Causes Control 2:325–357, 1991.Google Scholar
  94. 94.
    Steinmetz KA, Potter JD. Vegetables, Fruit, and Cancer. II. Mechanisms. Cancer Causes Control 2:427–442, 1991.Google Scholar
  95. 95.
    Wattenberg LW. Inhibition of Chemical Carcineogenesis. Journal of the National Institute of Cancer 60:11–18, 1978.Google Scholar
  96. 96.
    Frommel TO, Mobarhan S, et al. Effect of Beta-Carotene Supplementation on Indices of Colonic Cell Proliferation. Journal of the National Cancer Institute 87:1781–1787, 1995.PubMedGoogle Scholar
  97. 97.
    McBurney M, Costa S, Pratt M. Retinoids and Cancer: A Basis for Differentiation Therapy. Cancer Investigations 11:590–598, 1993.Google Scholar
  98. 98.
    Rock CL. Carotenoids: Biology and Treatment. Pharmacologic Therapy 75:185,1997.Google Scholar
  99. 99.
    Gaby SK, Machlin U. Vitamin E. In: Vitamin Intake and Health; Gaby SK, Bendich A, Singh VN, Machlin LJ, Eds. New York (NY): Marcel Dekker 71, 1991.Google Scholar
  100. 100.
    Farrell PM, Roberts RJ. Vitamin E. In: Modem Nutrition in Health and Disease; Shils ME, Olson JA, Shike M, Eds. Philadelphia (PA): Lea & Febiger 326, 1994.Google Scholar
  101. 101.
    Rock CL. Nutritional Factors in Cancer Prevention. Hematology/Oncology Clinics of North America 12:975–991, 1998.PubMedGoogle Scholar
  102. 102.
    Hennekens CH, Buring JE, et al. Lack of Effect of Long-Term Supplementation with Beta-Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease. New England Journal of Medicine 334:1145–1149, 1996.PubMedGoogle Scholar
  103. 103.
    Albanes D, Heinonen OP, et al. Effects of a-Tocopherol and 13-Carotene Supplements on Cancer Incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. American Journal of Clinical Nutrition S62: 1427–1430, 1995.Google Scholar
  104. 104.
    Greenberg RE, Baron JA, et al. A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma. New England Journal of Medicine 331:141–147, 1994.PubMedGoogle Scholar
  105. 105.
    DeCosse JJ, Miller HH, and Lesser ML. Effect of Wheat Fiber and Vitamins C and E on Rectal Polyps in Patients with Familial Adenomatous Polyposis. Journal of the National Cancer Institute 81:1290–1297, 1989.PubMedGoogle Scholar
  106. 106.
    McKeown-Eyssen G, Holloway C. et al. A Randomized Trial of Vitamins C and E in the Prevention of Recurrence of Colorectal Polyps. Cancer Research 48:4701–4705, 1988PubMedGoogle Scholar
  107. 107.
    Pagnelli GM, Biasco G, et al. Effect of Vitamin A, C, and E Supplementation on Rectal Cell Proliferation in Patients with Colorectal Adenomas. Journal to the National Cancer Institute 84:47–51, 1992.Google Scholar
  108. 108.
    Ponz de Leon M, Roncucci L. Chemoprevention of Colorectal Tumors: Role of Lactulose and of Other Agents. Scandanavian Journal of Gastroenterology S222: 72–75, 1997.Google Scholar
  109. 109.
    Giovannucci E, Rimm EB, et al. Intake of Fat, Meat, and Fiber in Relation to Risk of Colon Cancer in Men. Cancer Research 54:2390–2397, 1994.PubMedGoogle Scholar
  110. 110.
    Fuchs CS, Giovannucci EL, et al. Dietary Fiber and the Risk of Colorectal Cancer and Adenoma in Women. New England Journal of Medicine 340:169–176, 1999.PubMedGoogle Scholar
  111. 111.
    Doll R, Peto R. The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United Sates Today. Journal of the National Cancer Institute 66:1191–1308, 1981.PubMedGoogle Scholar
  112. 112.
    Ranken R, Wilson R, Bealmear PM. Increased Turnover of Intestinal Mucosal Cells of Germfree Mice Induced by Cholic Acid. Proceedings of the Society of experimental Biology and Medicine 138:270–272, 1971.Google Scholar
  113. 113.
    Hill MJ. The Role of Unsaturated Bile Acids in the Etiology of Large Bowel Cancer. In: Origins of Human cancer. (Hiatt HH, Watson JD, Winsten JA, Eds.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1977.Google Scholar
  114. 114.
    Reddy BS. Diet and Excretion of Bile Acids. Cancer Research 41:3766–3768, 1981.PubMedGoogle Scholar
  115. 115.
    Alberts DS, Einspahr J, et al. Effects of Dietary Wheat Bran Fiber on Rectal Epithelial Cell Proliferation in Patients with Resection For Colorectal Cancers. Journal of the National Cancer Institute 82:1280–1285, 1990.PubMedGoogle Scholar
  116. 116.
    Hill MJ. Bile Acids and Colorectal Cancer: Hypothesis. European Journal of Cancer Prevention 1 supp 2:69–74, 1991.Google Scholar
  117. 117.
    Trock B, Lanza E, Greenwald P. Dietary Fiber, Vegetables, and Colon Cancer: Critical Review and Meta-analyses of the Epidemiologic Evidence. Journal of the National Cancer Institute 82:650–661, 1990.PubMedGoogle Scholar
  118. 118.
    Howe GR, Benito E, et al. Dietary Intake of Fiber and Decreased Risk of Cancers of the Colon and Rectum: Evidence From the Combined Analysis of 13 Case-Control Studies. Journal of the National Cancer Institute 84:1887–1896, 1992.PubMedGoogle Scholar
  119. 119.
    World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, and the Prevention of Cancer: A Global Perspective, pp216–251. Washington, DC: American Institute for Cancer Research, 1997.Google Scholar
  120. 120.
    Caygill CP, Carlett A and Hill MJ. Fat, Fish, Fish Oil and Cancer. British Journal of Cancer 74:159–164, 1996.PubMedGoogle Scholar
  121. 121.
    Schatzkin A, Lanza E, et al. Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas. New England Journal of Medicine 342:1149–1155, 2000.PubMedGoogle Scholar
  122. 122.
    Alberts DS, Martinez ME, et al. Lack of Effect of a High-Fiber Cereal Supplement on the Recurrence Rate of Colorectal Adenomas. New England Journal of Medicine 342:1156–1162, 2000.PubMedGoogle Scholar
  123. 123.
    Cravo M, Mason J, et al. Folate Deficiency Enhances the Development of Colonic Neoplasia in Dimethylhydrazine (DMH) Treated Rats. Cancer Research 52:5002–5006, 1992.PubMedGoogle Scholar
  124. 124.
    Cravo M, Mason J, et al. Folate Deficiency in Rats Causes Hypomethylation of Liver DNA. FASEB Journal 4:A914, 1991.Google Scholar
  125. 125.
    Giovannucci E, Stampfer MJ, et al. Folate, Methionine, and Alcohol Intake and Risk of Colorectal Adenoma. Journal of the National Cancer Institute 85:875–884, 1993.PubMedGoogle Scholar
  126. 126.
    Giovannucci E, Rimm EB, et al. Alcohol, Low Methionine-Low Folate Diets, and Risk of Colon Cancer in Men. Journal of the National Cancer Institute 87:265–273, 1995.PubMedGoogle Scholar
  127. 127.
    Glynn SA, Albanes D, et al. Colorectal Cancer and Folate Status: A Nested Case-control Study Among Male Smokers. Cancer Epidemiology, Biomarkers & Prevention 5:487–494, 1996.Google Scholar
  128. 128.
    Halsted CH, Gandhi G, et al. Sulfasalazine Inhibits the Absorption of Folates in Ulcerative Colitis. New England Journal of Medicine 305:1513–1517, 1981.PubMedGoogle Scholar
  129. 129.
    Lashner BA. Red Blood Cell Folate is Associated with the Development of Dysplasia and Cancer in Ulcerative Colitis. Journal of Cancer Research and Clinical Oncology 119:549–554, 1993.PubMedGoogle Scholar
  130. 130.
    Lashner BA, Heidenreich PA, et al. Effect of Folate Supplementation on the Incidence of Dysplasia and Cancer in Chronic Ulcerative Colitis. A Case-control Study. Gastroenterology 97:255–259, 1989.PubMedGoogle Scholar
  131. 131.
    Giovannucci E, Stampfer MJ, et al. Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses’ Health Study. Annals of Internal Medicine 129:517–524, 1998.PubMedGoogle Scholar
  132. 132.
    Lieberman DA, Weiss DG, et al. Use of Colonoscopy to Screen asymptomatic Adults for Colorectal Cancer. New England Journal of Medicine 343:162–168, 2000.PubMedGoogle Scholar
  133. 133.
    Imperiale TF, Wagner DR, et al. Risk of Advanced Proximal Neoplasms in Asymptomatic Adults according to the Distal Colorectal Findings. New England Journal of Medicine 343:168–174, 2000.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Mary Mulcahy
  • Al BensonIII

There are no affiliations available

Personalised recommendations